Latest News and Press Releases
Want to stay updated on the latest news?
-
Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
-
Robbins LLP is Investigating Allegations that Gossamer Bio, Inc. (GOSS) Misled Investors Regarding the Viability of its PROSERA Study
-
Robbins LLP is Investigating Allegations that Zynex, Inc. (ZYXIQ) Filed False Claims and Failed to Comply with Industry Regulations
-
Robbins LLP is Investigating Allegations that Avantor, Inc. (AVTR) Mislead Investors Regarding the Effects of Increased Competition
-
Robbins LLP is Investigating Allegations that aTyr Pharma, Inc. (ATYR) Mislead Investors Regarding the Efficacy of its Drug Candidate
-
Robbins LLP is Investigating Allegations that Savara Inc. (SVRA) Misled Investors About the Viability of its Lead Drug Candidate
-
Dallas, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) acknowledges the perspectives and concerns raised by attorneys general regarding the safety...
-
LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Southern California Biomedical Council (SoCalBio) is proud to conclude the 2024 26th Annual Investor & Partnering Conference in Newport Beach, held...
-
The Southern California Biomedical Council announced the full lineup of speakers and presenting companies for its 26th Annual SoCalBio Investor Conference.
-
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare...